Ubs Oconnor LLC Annexon, Inc. Transaction History

Ubs Oconnor LLC

$2.23 Billion
Q2 2025

A detailed history of Ubs Oconnor LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 492,698 shares of ANNX stock, worth $1.55 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

492,698

Holding current value

$1.55 Million

% of portfolio

0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.38 - $2.73 $35,713 - $70,649	25,879 Added 5.54%	492,698 $1.18 Million
Q1 2025 May 15, 2025	BUY	$1.93 - $5.5 $285,514 - $813,642	147,935 Added 46.39%	466,819 $900,000
Q4 2024 Feb 14, 2025	SELL	$4.44 - $7.63 $7,503 - $12,894	-1,690 Reduced 0.53%	318,884 $1.64 Million
Q3 2024 Nov 14, 2024	BUY	$4.49 - $7.2 $414,413 - $664,538	92,297 Added 40.43%	320,574 $1.9 Million
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $86,600 - $135,800	-20,000 Reduced 8.06%	228,277 $1.12 Million
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $1.79 Million - $3.47 Million	-444,651 Reduced 64.17%	248,277 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $234,201 - $665,247	143,682 Added 26.16%	692,928 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $263,459 - $474,969	123,690 Added 29.07%	549,246 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $893,667 - $2.71 Million	425,556 New	425,556 $1.5 Billion
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $29,725 - $59,292	7,948 Added 5.0%	166,907 $642,000
Q4 2022 Feb 14, 2023	BUY	$4.56 - $6.61 $169,641 - $245,905	37,202 Added 30.55%	158,959 $0
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $37,848 - $66,916	-10,093 Reduced 7.65%	121,757 $752 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $264,066 - $508,108	-125,150 Reduced 48.7%	131,850 $497,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $701,610 - $3.07 Million	257,000 New	257,000 $701,000

Others Institutions Holding ANNX

# of Institutions

140

Shares Held

96.5M

Call Options Held

Put Options Held

63.4K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $150M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account